One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1016/j.annonc.2023.09.2755
Copy DOI Journal: Annals of Oncology |  Publication Date: Oct 1, 2023 |
Affiliation: National Cancer Center Hospital East, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituti di Ricovero e Cura a Carattere Scientifico, Vall d'Hebron Hospital Universitari, Peter MacCallum Cancer Centre, University of Auckland, Auckland City Hospital, Centre Jean Bernard, Clinique Victor Hugo, Carolina Urologic Research Center, University Hospital Heidelberg, Heidelberg University, National Center for Tumor Diseases, University of Glasgow, Beatson West of Scotland Cancer Centre, Pfizer (United States), The Urology Center of Colorado, Pontifícia Universidade Católica do Rio Grande do Sul, Institut de Cancérologie Strasbourg, National Cancer Center, Institut Gustave Roussy, Institut Polytechnique de Paris, University of Paris-Saclay, Arizona Pain Specialists, University of Utah, Huntsman Cancer Institute1807P Talazoparib (TALA) plus enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): Subgroup analyses of the all-comers cohort from TALAPRO-2 by homologous recombination repair (HRR) status
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
